GB201405264D0 - Modified antibodies containing lgG2 Domains which possess agonist or antagonistic properties and therapeutic use thereof - Google Patents
Modified antibodies containing lgG2 Domains which possess agonist or antagonistic properties and therapeutic use thereofInfo
- Publication number
- GB201405264D0 GB201405264D0 GB201405264A GB201405264A GB201405264D0 GB 201405264 D0 GB201405264 D0 GB 201405264D0 GB 201405264 A GB201405264 A GB 201405264A GB 201405264 A GB201405264 A GB 201405264A GB 201405264 D0 GB201405264 D0 GB 201405264D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- lgg2
- domains
- therapeutic use
- modified antibodies
- antibodies containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201405264A GB201405264D0 (en) | 2014-03-24 | 2014-03-24 | Modified antibodies containing lgG2 Domains which possess agonist or antagonistic properties and therapeutic use thereof |
CA2943167A CA2943167A1 (en) | 2014-03-24 | 2015-03-24 | Modified antibodies containing modified igg2 domains which elicit agonist or antagonistic properties and use thereof |
AU2015237864A AU2015237864B2 (en) | 2014-03-24 | 2015-03-24 | Modified antibodies containing modified IgG2 domains which elicit agonist or antagonistic properties and use thereof |
EP19175308.6A EP3590967A1 (en) | 2014-03-24 | 2015-03-24 | Modified antibodies containing modified igg2 domains which elicit agonist properties and use thereof |
PCT/IB2015/052166 WO2015145360A1 (en) | 2014-03-24 | 2015-03-24 | Modified antibodies containing modified igg2 domains which elicit agonist or antagonistic properties and use thereof |
US15/128,781 US11059898B2 (en) | 2014-03-24 | 2015-03-24 | Modified antibodies containing modified IGG2 domains which elicit agonist or antagonistic properties and use thereof |
CN201580023010.XA CN107172880B (en) | 2014-03-24 | 2015-03-24 | Modified antibodies comprising a modified IgG2 domain that elicit agonistic or antagonistic properties and uses thereof |
JP2017501529A JP6682498B2 (en) | 2014-03-24 | 2015-03-24 | Modified antibodies containing modified IgG2 domains that induce agonistic or antagonistic properties and uses thereof |
EP15716147.2A EP3122779B1 (en) | 2014-03-24 | 2015-03-24 | Modified antibodies containing modified igg2 domains which elicit agonist or antagonistic properties and use thereof |
CN202111024797.5A CN113912723A (en) | 2014-03-24 | 2015-03-24 | Modified antibodies comprising a modified IgG2 domain that elicit agonistic or antagonistic properties and uses thereof |
JP2019204004A JP2020037577A (en) | 2014-03-24 | 2019-11-11 | MODIFIED ANTIBODIES CONTAINING MODIFIED IgG2 DOMAINS WHICH ELICIT AGONISTIC OR ANTAGONISTIC PROPERTIES AND USE THEREOF |
US17/327,837 US20210347907A1 (en) | 2014-03-24 | 2021-05-24 | Modified antibodies containing modified igg2 domains which elicit agonist or antagonistic properties and use thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201405264A GB201405264D0 (en) | 2014-03-24 | 2014-03-24 | Modified antibodies containing lgG2 Domains which possess agonist or antagonistic properties and therapeutic use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201405264D0 true GB201405264D0 (en) | 2014-05-07 |
Family
ID=50686827
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB201405264A Ceased GB201405264D0 (en) | 2014-03-24 | 2014-03-24 | Modified antibodies containing lgG2 Domains which possess agonist or antagonistic properties and therapeutic use thereof |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201405264D0 (en) |
-
2014
- 2014-03-24 GB GB201405264A patent/GB201405264D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL304178A (en) | Anti-gitr antibodies and methods of use thereof | |
IL279606A (en) | Anti-trem2 antibodies and methods of use thereof | |
HK1245807A1 (en) | Anti-mertk agonistic antibodies and uses thereof | |
HK1249445A1 (en) | Anti-sortilin antibodies and methods of use thereof | |
HK1252698A1 (en) | Anti-siglec-9 antibodies and methods of use thereof | |
IL259495A (en) | Antibodies and methods of use thereof | |
HK1252696A1 (en) | Anti-siglec-7 antibodies and methods of use thereof | |
SG10201912150TA (en) | Anti-trem2 antibodies and methods of use thereof | |
ZA202001985B (en) | Anti-htra1 antibodies and methods of use thereof | |
IL250428B (en) | Antagonistic anti-ox40l antibodies and methods of their use | |
GB201405275D0 (en) | Modified antibodies containing lgG2 Domains which possess agonist or antagonistic properties and therapeutic use thereof | |
GB201405264D0 (en) | Modified antibodies containing lgG2 Domains which possess agonist or antagonistic properties and therapeutic use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |